Tag Archives: Chief Executive Office

MOD-PAC Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Going Private Agreeme

By Business Wirevia The Motley Fool

Filed under:

MOD-PAC Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Going Private Agreement

DALLAS–(BUSINESS WIRE)– Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of MOD-PAC Corp. (“MPAC“) (NasdaqGM: MPAC) to Kevin T. Keane, Chairman of the company, and Daniel G. Keane, President and Chief Executive Office, and their affiliates and associates for shareholders. Under the terms of the proposed going private deal, MPAC shareholders will only receive $8.40 in cash for each share of MPAC stock owned.

If you are an affected investor, and you want to learn more about the lawsuit or join the action, please contact Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 239-4568, via email at WBriscoe@TheBriscoeLawFirm.com or Zach Groover at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at zach@powerstaylor.com. There is no cost or fee to you.

The MPAC sale investigation centers on whether MPAC‘s shareholders are receiving adequate compensation for their shares in the proposed going private deal, whether the transaction undervalues MPAC‘s stock, and whether MPAC‘s board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal. According to shareholder rights attorney Willie Briscoe, “due to the relationship of the parties, the lack of a significant premium and other factors, we believe this transaction may undervalue MPAC‘s stock. Our proposed lawsuit will seek to obtain the highest share price for all shareholders.”

The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Powers Taylor, LLP is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.

The Briscoe Law Firm, PLLC
Willie Briscoe, 214-239-4568
WBriscoe@TheBriscoeLawFirm.com
or
Powers Taylor, LLP
Zach Groover, 877-728-9607
zach@powerstaylor.com

KEYWORDS:   United States  North America  Texas

INDUSTRY KEYWORDS:

The article MOD-PAC Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Going Private Agreement originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30

From: http://www.dailyfinance.com/2013/04/11/mod-pac-shareholder-alert-briscoe-law-firm-and-pow/

DexCom Announces Upcoming Conference Presentations

By Business Wirevia The Motley Fool

Filed under:

DexCom Announces Upcoming Conference Presentations

SAN DIEGO–(BUSINESS WIRE)– DexCom, Inc. (NAS: DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:

  • Terry Gregg, Chief Executive Office, will present an update on DexCom at the Barclays Global Healthcare Conference in Miami, Florida on Wednesday, March 13, 2013 at 2:30 p.m. (EST). The presentation, which will occur live at the Loews Miami Hotel, will be concurrently webcast.
  • Steve Pacelli, EVP, Strategy and Corporate Development, will present an update on DexCom at the 25th Annual ROTH Conference in Laguna Niguel, California on Monday, March 18, 2013 at 11:30 a.m. (PST). The presentation, which will occur live at the Ritz-Carlton, Laguna Niguel, will be concurrently webcast.

The link to each webcast will be available on the DexCom website at www.dexcom.com by navigating to “About”, then “Investor Relations”, and then “Events and Webcasts”, and the presentations will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

Cautionary Statement Regarding Forward Looking Statements

DexCom is a medical device company with a limited operating history. Successful commercialization of the company’s products is subject to numerous risks and uncertainties, including a lack of acceptance in the marketplace by physicians and patients, the inability to manufacture products in commercial quantities at an acceptable cost, possible delays in the company’s development programs, the inability of patients to receive reimbursement from third-party payors and inadequate financial and other resources. Certain of these risks and uncertainties, in addition to other risks, are more fully described in the company’s annual report on Form 10-K for the fiscal year ended December 31, 2012, as filed with the Securities and Exchange Commission on February 21, 2013.

DexCom, Inc.
Steven R. Pacelli
Executive Vice President, Strategy and Corporate Development
858-200-0200

KEYWORDS: …read more
Source: FULL ARTICLE at DailyFinance